日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Direct evaluation of antiplatelet therapy in coronary artery disease by comprehensive image-based profiling of circulating platelets

通过对循环血小板进行全面的基于图像的分析,直接评估抗血小板治疗在冠状动脉疾病中的疗效

Hirose, Kazutoshi; Kodera, Satoshi; Nishikawa, Masako; Sato, Masataka; Zhou, Yuqi; Zhang, Hongqian; Minatsuki, Shun; Ishida, Junichi; Takeda, Norifumi; Wang, Huidong; Kong, Chuiming; Deng, Yunjie; Chen, Junyu; Zhang, Chenqi; Akita, Jun; Ibayashi, Yuma; Yang, Ruoxi; Kanno, Hiroshi; Nitta, Nao; Sugimura, Takeaki; Takeda, Norihiko; Kurano, Makoto; Yatomi, Yutaka; Goda, Keisuke

Genetic Diversity Evaluation of 70 Chewing Cane Germplasm Resources Based on Phenotypic Traits

基于表型性状的70份咀嚼甘蔗种质资源遗传多样性评价

Xie, Jing; Liu, Zhuang; Chang, Hailong; Zhang, Chuiming; Liang, Qinggan; Wang, Zhuqing; Cheng, Yinjie; Wang, Qinnan; Wu, Jiantao

The Relationship Between IL-6 and IL-10 Expression Levels and the Prognosis in B-Cell Non-Hodgkin Lymphoma Patients Treated with R-CHOP

IL-6 和 IL-10 表达水平与接受 R-CHOP 方案治疗的 B 细胞非霍奇金淋巴瘤患者预后的关系

Dong, Quan; Lin, Wenxin; Yu, Saihui; Qin, Yuxin; Jia, Chuiming; Wang, Na; Xiu, Wei; Shan, Weiqi; Dong, Mei; Liu, Duo

Prognostic marker CD27 and its micro-environmental in multiple myeloma

多发性骨髓瘤的预后标志物 CD27 及其微环境

Xinya Wang #, Keyang Luo #, Qiuting Xu, Liqun Chi, Yiwei Guo, Chuiming Jia, Lina Quan

Correction: HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma

更正:HNRNPA2B1介导的TLR4 mRNA m6A修饰促进多发性骨髓瘤的进展

Jia, Chuiming; Guo, Yiwei; Chen, Yao; Wang, Xinya; Xu, Qiuting; Zhang, Yu; Quan, Lina

HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma

HNRNPA2B1 介导的 TLR4 mRNA m6A 修饰促进多发性骨髓瘤进展

Chuiming Jia, Yiwei Guo, Yao Chen, Xinya Wang, Qiuting Xu, Yu Zhang, Lina Quan

Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo

膜联蛋白 A1 敲低和硼替佐米联合治疗对多发性骨髓瘤的体内外增强抗肿瘤作用

Chuiming Jia, Dejuan Kong, Yiwei Guo, Lianqiao Li, Lina Quan